BSE · 544365
Shanmuga Hospital Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹48 Cr with net profit ₹4 Cr — a 8.76% net margin, versus 8.75% the period before.
Shareholding
As of 2026-03-31
- Promoter72.06%
- Public27.94%
1,008 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.67× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #43 of 85 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,27,968 Cr | 60.82 | 13.5 | 20.48% | 7.91% |
| Max Healthcare Institute Ltd. | ₹1,01,088 Cr | 67.53 | 9.41 | 13.42% | 16.73% |
| Manipal Health Enterpri Limited | ₹96,450 Cr | 102.84 | 5.87 | 10.59% | 7.81% |
| Fortis Healthcare Ltd. | ₹68,131 Cr | 63.87 | 6.89 | 10.53% | 11.02% |
| Aster DM Quality Care Ltd. | ₹66,888 Cr | 172.44 | 15.9 | 8.48% | 6.54% |
| Global Health Limited | ₹39,245 Cr | 68.56 | 9.91 | 14.05% | 11.88% |
| Narayana Hrudayalaya Ltd. | ₹39,027 Cr | 45.28 | 8.6 | 17.76% | 9% |
| Krishna Institute of Medical Sciences Ltd. | ₹32,458 Cr | 155.49 | 8.66 | 10.74% | 4.85% |
| Dr. Lal Path Labs Ltd. | ₹32,172 Cr | 57.2 | 12.83 | 20.13% | 18.75% |
| Poly Medicure Ltd. | ₹17,743 Cr | 55.45 | 5.71 | 10.37% | 15.77% |
| Shanmuga Hospital Limited(this company) | ₹67 Cr | 15.8 | 1.58 | 9.91% | 8.89% |
AI analysis
AI-generated · google/gemini-2.5-flashShanmuga Hospital Limited is listed on the Indian markets. The company reported annual revenue of Rs 48.09 Cr for March 2025.
Positives
- +The debt-to-equity ratio is 0.29, indicating lower reliance on borrowed funds.
- +Promoter holding of 72.06% as of March 31, 2026.
Negatives
- −Net profit decreased by 19.83% from Rs 5.25 Cr in March 2024 to Rs 4.21 Cr in March 2025.
- −Earnings per share decreased from Rs 5.36 in March 2024 to Rs 4.03 in March 2025.
- −Annual revenue growth data is not available.
- −No quarterly results have been disclosed.
Financial performance
Shanmuga Hospital Limited reported annual revenue of Rs 48.09 Cr in March 2025. This represents an increase from Rs 43.39 Cr in March 2024. Net profit for March 2025 was Rs 4.21 Cr, following Rs 5.25 Cr in March 2024. Earnings per share were Rs 4.03 in March 2025, a decrease from Rs 5.36 in March 2024.
Balance sheet
The company's debt-to-equity ratio stands at 0.29. No other balance sheet figures are available for analysis.
Ownership & pledges
Public shareholding is 27.94%. There is no reported pledge of promoter shares. The number of shareholders as of March 31, 2026, was 1008.
Shareholding changes
Promoter holding has remained at 72.06% from September 30, 2025, to March 31, 2026. However, it decreased from 72.11% in March 2025. Public holding increased from 27.69% in March 2025 to 27.94% in March 2026. The number of shareholders decreased from 1449 in March 2025 to 1008 in March 2026.
Data as of — price: 2026-09-10 · financials: Mar 26 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.